Tizepatide CAS 2023788-19-2TR5 TR10 TR15 TR20 TR30 TR40 TR50 TR60 TR120

                                                                       WhatsApp: +85266976540

                                                                                          +85252797286

Telzepatide is a novel synthetic dual-receptor agonist peptide that has attracted widespread attention in global biochemistry and preclinical research. As a laboratory-grade lyophilized peptide, it is widely used in scientific exploration of metabolic regulation mechanisms, receptor signaling pathways, and related preclinical models. Telzepatide can simultaneously activate both glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This unique dual-target mechanism distinguishes it from single-target peptide analogs and provides researchers with a new tool for studying multiple metabolic signal transduction networks. It must be clearly emphasized that this product is for laboratory research use only.

In terms of molecular mechanisms, Telzepatide can bind to and activate GIP and GLP-1 receptors distributed in multiple target organs. Under physiologically simulated conditions, activation of GLP-1 receptors participates in regulating glucose-related signal feedback. Simultaneously, activation of GIP receptors produces synergistic biological effects, jointly participating in energy metabolism, glucose homeostasis, and appetite-related neural signaling pathways. GLP-1-related receptors are widely distributed in the pancreas, gastrointestinal tract, central nervous system, and adipose tissue; GIP receptors are also expressed in the islets of Langerhans, brain, and adipose tissue. Co-activation of these two receptor systems can produce complex biological effects that cannot be fully achieved by a single receptor agonist. Researchers utilize this characteristic to conduct comparative experiments, exploring the differences in metabolic regulation between single-target and dual-target activation.

In preclinical research models, telapatetide exhibits a variety of observable biological phenotypes. In glucose metabolism studies, it participates in the regulation of pancreatic islet cell function. Under high glucose experimental conditions, telapatetide helps researchers observe the secretion patterns of insulin and related islet hormones, exploring how peptide molecules help the body maintain stable blood glucose levels. Many laboratory projects use telapatetide as a tool compound to verify the correlation between peptide receptor activation and blood glucose fluctuations, providing experimental data to support the understanding of the pathological mechanisms of glucose metabolism disorders.

In studies related to energy balance and food intake, telapatetide is an important research reagent for studying central appetite regulation pathways. When used as a central nervous system receptor target in animal models, it affects neural signals related to feeding behavior. Researchers record changes in food intake, body weight, and adipose tissue index in experimental animals to analyze how dual-receptor peptides participate in the regulation of systemic energy balance. These findings are primarily used for academic publication, mechanism validation, and compound comparison and screening, rather than to guide human weight management. Adipose tissue research is also a key research area. Related laboratory experiments mainly observe the effects of tezoparatide signaling activation on adipocyte differentiation, lipid breakdown, and the expression of inflammatory factors in adipose tissue, helping scientists further understand the complex regulatory network of lipid metabolism.

In addition to core metabolic research, tezoparatide is also used to explore multi-organ-related mechanisms. Pancreatic islet function research is one of its important research directions. Laboratory research focuses on the survival, proliferation, and hormone secretion function of islet cells under peptide intervention, investigating whether dual-receptor activation exerts a protective phenotypic effect on islet cells under pathological model conditions. Gastrointestinal biological responses are another research hotspot. GLP-1 and GIP receptors are highly expressed in gastrointestinal mucosa. Researchers use tezoparatide to study changes in gastrointestinal motility, gastrointestinal hormone release profiles, and the interaction between gut and systemic metabolism. Tezoparatide is also chosen as a tool in cardiovascular-related basic research. In preclinical animal models, scientists explored the indirect effects of metabolic improvement signals on vascular endothelial status, lipid profile indicators, and myocardial tissue markers, accumulating fundamental experimental data to lay the foundation for subsequent peptide drug development.

From the perspective of the material properties of peptide drugs, laboratory-grade tezoparatide is typically supplied in the form of a white lyophilized powder. Lyophilization technology effectively maintains molecular stability and slows down the degradation of peptide drugs caused by various factors.